BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3924
+0.0223 (6.03%)
At close: Aug 13, 2025, 4:00 PM
0.3924
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:36 AM EDT
BioAtla Employees
BioAtla had 61 employees as of December 31, 2024. The number of employees decreased by 4 or -6.15% compared to the previous year.
Employees
61
Change (1Y)
-4
Growth (1Y)
-6.15%
Revenue / Employee
$180,328
Profits / Employee
-$975,656
Market Cap
23.04M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 61 | -4 | -6.15% |
Dec 31, 2023 | 65 | -1 | -1.52% |
Dec 31, 2022 | 66 | 10 | 17.86% |
Dec 31, 2021 | 56 | 20 | 55.56% |
Dec 31, 2020 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BCAB News
- 5 days ago - BioAtla, Inc. (BCAB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress - GlobeNewsWire
- 10 days ago - BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025 - GlobeNewsWire
- 4 weeks ago - BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting - GlobeNewsWire
- 6 weeks ago - BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress - GlobeNewsWire
- 2 months ago - BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen - GlobeNewsWire
- 3 months ago - BioAtla, Inc. (BCAB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress - GlobeNewsWire